129 related articles for article (PubMed ID: 35489731)
21. Influence of the Preoperative C-Reactive Protein-to-Albumin Ratio on Survival and Recurrence in Patients With Esophageal Cancer.
Tamagawa H; Aoyama T; Tamagawa A; Komori K; Maezawa Y; Kano K; Murakawa M; Atsumi Y; Hara K; Kazama K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Apr; 40(4):2365-2371. PubMed ID: 32234939
[TBL] [Abstract][Full Text] [Related]
22. Systemic inflammation score in locally advanced rectal cancer patients following total mesorectal excision.
Feng Y; Liu L; Zhu Y
Onco Targets Ther; 2019; 12():6617-6622. PubMed ID: 31695404
[TBL] [Abstract][Full Text] [Related]
23. The clinical impacts of lymphocyte-to-C-reactive protein ratio for esophageal cancer patients who receive curative treatment.
Aoyama T; Nagasawa S; Nakazono M; Segami K; Tamagawa H; Tamagawa A; Hara K; Oshima T; Yukawa N; Masuda M; Rino Y
J Cancer Res Ther; 2023; 19(3):556-561. PubMed ID: 37470574
[TBL] [Abstract][Full Text] [Related]
24. Impact of inflammation-based prognostic score on survival after curative thoracoscopic esophagectomy for esophageal cancer.
Hirahara N; Matsubara T; Hayashi H; Takai K; Fujii Y; Tajima Y
Eur J Surg Oncol; 2015 Oct; 41(10):1308-15. PubMed ID: 26235238
[TBL] [Abstract][Full Text] [Related]
25. [Effect of preoperative Nutritional Risk Screening-2002 combined with hematologic inflammatory markers on prognosis of thoracic esophageal squamous cell carcinoma].
Guo XW; Zhu L; Ye HX; Zhou SB; Liu YC; Zhou JY; Ji SJ
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):604-609. PubMed ID: 31434452
[No Abstract] [Full Text] [Related]
26. Pretreatment NRS-2002 scores combined with hematologic inflammation markers are independent prognostic factors in patients with resectable thoracic esophageal squamous cell carcinoma.
Guo XW; Liu YC; Gao F; Ji SJ; Zhou JY; Ji L; Zhou SB
Cancer Manag Res; 2018; 10():2409-2418. PubMed ID: 30122990
[TBL] [Abstract][Full Text] [Related]
27. Prognostic importance of the preoperative modified systemic inflammation score for patients with gastric cancer.
Lin JX; Lin JP; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu R; Zheng CH; Huang CM; Li P
Gastric Cancer; 2019 Mar; 22(2):403-412. PubMed ID: 29982861
[TBL] [Abstract][Full Text] [Related]
28. Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis.
Huang W; Wu L; Liu X; Long H; Rong T; Ma G
J Cardiothorac Surg; 2019 Sep; 14(1):167. PubMed ID: 31533862
[TBL] [Abstract][Full Text] [Related]
29. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
30. Preoperative Glasgow Prognostic Score as additional independent prognostic parameter for patients with esophageal cancer after curative esophagectomy.
Lindenmann J; Fink-Neuboeck N; Avian A; Pichler M; Habitzruther M; Maier A; Smolle-Juettner FM
Eur J Surg Oncol; 2017 Feb; 43(2):445-453. PubMed ID: 27839896
[TBL] [Abstract][Full Text] [Related]
31. Clinical Influence of Anastomotic Leakage on Esophageal Cancer Survival and Recurrence.
Aoyama T; Kazama K; Atsumi Y; Tamagawa H; Tamagawa A; Komori K; Machida D; Maezawa Y; Kano K; Hara K; Murakawa M; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
Anticancer Res; 2020 Jan; 40(1):443-449. PubMed ID: 31892599
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma.
Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF
Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745
[TBL] [Abstract][Full Text] [Related]
33. Impact of combined assessment of systemic inflammation and presarcopenia on survival for surgically resected esophageal cancer.
Sakai M; Sohda M; Saito H; Ubukata Y; Nakazawa N; Kuriyama K; Hara K; Sano A; Ogata K; Yokobori T; Shirabe K; Saeki H
Am J Surg; 2021 Jan; 221(1):149-154. PubMed ID: 32594999
[TBL] [Abstract][Full Text] [Related]
34. Systemic Inflammation Score as a Novel Prognostic Indicator for Patients Undergoing Video-Assisted Thoracoscopic Surgery Lobectomy for Non-Small-Cell Lung Cancer.
Li S; Zhang W; Yang Z; Li Y; Du H; Che G
J Invest Surg; 2021 Apr; 34(4):428-440. PubMed ID: 31304810
[TBL] [Abstract][Full Text] [Related]
35. Low Preoperative Albumin-to-Globulin Ratio Is a Marker of Poor Prognosis in Patients With Esophageal Cancer.
Atsumi Y; Kawahara S; Kakuta S; Onodera A; Hara K; Kazama K; Numata M; Aoyama T; Tamagawa A; Tamagawa H; Oshima T; Yukawa N; Rino Y
In Vivo; 2021; 35(6):3555-3561. PubMed ID: 34697194
[TBL] [Abstract][Full Text] [Related]
36. [Prognostic influence of preoperative Nutritional Risk Screening -2002 (NRS-2002) score for patients with thoracic esophageal squamous cell carcinoma receiving surgery].
Sun HJ; Guo XW; Ji SJ; Zhou SB; Gu L
Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):917-921. PubMed ID: 30605983
[No Abstract] [Full Text] [Related]
37. Pretreatment Fibrinogen Level Is a Prognostic Factor for Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kawahara S; Kazama K; Komori K; Yoshizawa S; Tamagawa A; Tateishi M; Minami T; Cho H; Morita J; Otani K; Sawazaki S; Numata M; Tanabe M; Oshima T; Saito A; Yukawa N; Rino Y
Anticancer Res; 2024 Jan; 44(1):249-255. PubMed ID: 38159985
[TBL] [Abstract][Full Text] [Related]
38. Effect of perioperative flurbiprofen axetil on long-term survival of patients with esophageal carcinoma who underwent thoracoscopic esophagectomy: A retrospective study.
Xie Y; Wang D; Gao C; Hu J; Zhang M; Gao W; Shu S; Chai X
J Surg Oncol; 2021 Sep; 124(4):540-550. PubMed ID: 34143443
[TBL] [Abstract][Full Text] [Related]
39. The Naples Prognostic Score Is an Independent Prognostic Factor for Gastric Cancer Patients Who Receive Curative Treatment.
Aoyama T; Kato A; Hashimoto I; Maezawa Y; Hara K; Kazama K; Komori K; Tamagawa H; Tamagawa A; Nagasawa S; Cho H; Segami K; Nakazono M; Otani K; Sawazaki S; Numata M; Kamiya N; Yoshizawa S; Kawahara S; Oshima T; Saito A; Yukawa N; Rino Y
In Vivo; 2024; 38(2):890-896. PubMed ID: 38418121
[TBL] [Abstract][Full Text] [Related]
40. The Clinical Impact of the Age-adjusted Charlson Comorbidity Index on Esophageal Cancer Patients Who Receive Curative Treatment.
Aoyama T; Atsumi Y; Kawahara S; Tamagawa H; Tamagawa A; Ozawa Y; Maezawa Y; Kano K; Murakawa M; Kazama K; Segami K; Hara K; Numata M; Oshima T; Yukawa N; Masuda M; Rino Y
In Vivo; 2020; 34(5):2783-2790. PubMed ID: 32871815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
